NYMOX PHARMACEUTICAL CORP Annual Research And Development Expense in USD from 2015 to 2022

Taxonomy & unit
ifrs-full: USD
Summary
Nymox Pharmaceutical Corp quarterly/annual Research And Development Expense history and growth rate from 2015 to 2022.
  • Nymox Pharmaceutical Corp Research And Development Expense for the quarter ending September 30, 2023 was $661K, a 25.9% decline year-over-year.
  • Nymox Pharmaceutical Corp Research And Development Expense for the twelve months ending September 30, 2023 was -$288K, a 104% decline year-over-year.
  • Nymox Pharmaceutical Corp annual Research And Development Expense for 2022 was $3.77M, a 43.3% decline from 2021.
  • Nymox Pharmaceutical Corp annual Research And Development Expense for 2021 was $6.66M, a 18% decline from 2020.
  • Nymox Pharmaceutical Corp annual Research And Development Expense for 2020 was $8.12M, a 10.1% increase from 2019.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.77M -$2.89M -43.3% Jan 1, 2022 Dec 31, 2022 20-F 2023-05-02
2021 $6.66M -$1.46M -18% Jan 1, 2021 Dec 31, 2021 20-F 2023-05-02
2020 $8.12M +$743K +10.1% Jan 1, 2020 Dec 31, 2020 20-F 2023-05-02
2019 $7.38M +$700K +10.5% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-30
2018 $6.68M -$1.2M -15.2% Jan 1, 2018 Dec 31, 2018 20-F 2021-03-29
2017 $7.87M +$1.08M +15.8% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-30
2016 $6.8M -$1.85M -21.4% Jan 1, 2016 Dec 31, 2016 20-F 2019-03-29
2015 $8.65M Jan 1, 2015 Dec 31, 2015 20-F 2018-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.